Kimberly Parker
Psychiatric/Mental Health · Mauldin, SCNPI 1972538395
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,000 and has fallen 84.4% since, to $312 in 2025. Among psychiatric/mental health clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$687
- Axsome Therapeutics, Inc.$621
- Otsuka America Pharmaceutical, Inc.$483
- Vanda Pharmaceuticals Inc.$376
- Takeda Pharmaceuticals U.S.A., Inc.$366
- Lundbeck LLC$355
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,81799%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $687 |
| Axsome Therapeutics, Inc. | 21 | $621 |
| Otsuka America Pharmaceutical, Inc. | 33 | $483 |
| Vanda Pharmaceuticals Inc. | 18 | $376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $366 |
| Lundbeck LLC | 20 | $355 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $328 |
| Sunovion Pharmaceuticals Inc. | 15 | $279 |
| Alkermes, Inc. | 9 | $186 |
| Neos Therapeutics, LP | 14 | $178 |
| Johnson & Johnson | 7 | $134 |
| Idorsia Pharmaceuticals US Inc | 3 | $131 |
| Bausch Health US, LLC | 8 | $120 |
| Supernus Pharmaceuticals, Inc. | 6 | $105 |
| Neurocrine Biosciences, Inc. | 6 | $98 |
| Avanir Pharmaceuticals, Inc. | 7 | $95 |
| Teva Pharmaceuticals USA, Inc. | 4 | $93 |
| Acadia Pharmaceuticals Inc | 2 | $44 |
| Tris Pharma Inc | 2 | $39 |
| UCB, Inc. | 1 | $33 |
| Corium, LLC | 2 | $33 |
| Almatica Pharma LLC | 2 | $29 |
| Boston Scientific | 1 | $19 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,846 in reported general payments places this provider in the 90th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Other psychiatric/mental health in Mauldin
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Cerrissa HugieCharleston$54K
- Karen FulwoodMyrtle Beach$30K
- Taylor CrewsIsle Of Palms$28K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- Mary McManusNorth Myrtle Beach$15K
- Kelsie FowlerAnderson$15K
- William HendricksGreenville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.